39357422|t|Gut microbiome and metabolites mediate the benefits of caloric restriction in mice after acute kidney injury.
39357422|a|The role of gut microbiome in acute kidney injury (AKI) is increasing recognized. Caloric restriction (CR) has been shown to enhance the resistance to ischemia/reperfusion injury to the kidneys in rodents. Nonetheless, it is unknown whether intestinal microbiota mediated CR protection against ischemic/reperfusion-induced injury (IRI) in the kidneys. Herein, we showed that CR ameliorated IRI-elicited renal dysfunction, oxidative stress, apoptosis, and inflammation, along with enhanced intestinal barrier function. In addition, gut microbiota depletion blocked the favorable effects of CR in AKI mice. 16S rRNA and metabolomics analysis showed that CR enriched the gut commensal Parabacteroides goldsteinii (P. goldsteinii) and upregulated the level of serum metabolite dodecafluorpentan. Intestinal colonization of P. goldsteinii and oral administration of dodecafluorpentan showed the similar beneficial effects as CR in AKI mice. RNA sequencing and experimental data revealed that dodecafluorpentan protected against AKI-induced renal injury by antagonizing oxidative burst and NFkappaB-induced NLRP3 inflammasome activation. In addition, we screened and found that Hamaudol improved renal insufficiency by boosting the growth of P. goldsteinii. Our results shed light on the role of intestinal microbiota P. goldsteinii and serum metabolites dodecafluorpentan in CR benefits to AKI.
39357422	63	74	restriction	Disease	MESH:D002313
39357422	78	82	mice	Species	10090
39357422	89	108	acute kidney injury	Disease	MESH:D058186
39357422	140	159	acute kidney injury	Disease	MESH:D058186
39357422	161	164	AKI	Disease	MESH:D058186
39357422	200	211	restriction	Disease	MESH:D002313
39357422	213	215	CR	Disease	MESH:D002313
39357422	261	269	ischemia	Disease	MESH:D007511
39357422	270	288	reperfusion injury	Disease	MESH:D015427
39357422	382	384	CR	Disease	MESH:D002313
39357422	404	439	ischemic/reperfusion-induced injury	Disease	MESH:D015428
39357422	441	444	IRI	Disease	MESH:D015428
39357422	485	487	CR	Disease	MESH:D002313
39357422	500	503	IRI	Disease	MESH:D015428
39357422	513	530	renal dysfunction	Disease	MESH:D007674
39357422	565	577	inflammation	Disease	MESH:D007249
39357422	699	701	CR	Disease	MESH:D002313
39357422	705	708	AKI	Disease	MESH:D058186
39357422	709	713	mice	Species	10090
39357422	762	764	CR	Disease	MESH:D002313
39357422	792	819	Parabacteroides goldsteinii	Species	328812
39357422	821	835	P. goldsteinii	Species	328812
39357422	883	900	dodecafluorpentan	Chemical	-
39357422	929	943	P. goldsteinii	Species	328812
39357422	971	988	dodecafluorpentan	Chemical	-
39357422	1030	1032	CR	Disease	MESH:D002313
39357422	1036	1039	AKI	Disease	MESH:D058186
39357422	1040	1044	mice	Species	10090
39357422	1097	1114	dodecafluorpentan	Chemical	-
39357422	1133	1136	AKI	Disease	MESH:D058186
39357422	1145	1157	renal injury	Disease	MESH:D007674
39357422	1282	1290	Hamaudol	Chemical	MESH:C001324
39357422	1300	1319	renal insufficiency	Disease	MESH:D051437
39357422	1346	1360	P. goldsteinii	Species	328812
39357422	1422	1436	P. goldsteinii	Species	328812
39357422	1459	1476	dodecafluorpentan	Chemical	-
39357422	1480	1482	CR	Disease	MESH:D002313
39357422	1495	1498	AKI	Disease	MESH:D058186
39357422	Negative_Correlation	MESH:C001324	MESH:D051437

